Editas Medicine Market Sentiment

Editas Medicine Inc

EDITNASDAQ

Trade with Public

$2.58

-0.17-6.18%

가까이에: Sep 25, 5:00 PM EST

$2.60

0.020.78%

시간외: 7:57 PM EST

개요 뉴스 실적 전망 이벤트 목표가 재무심리지분 현황 비교 옵션 주식 보고서

Editas Medicine Market Sentiment

Market sentiment signals for Editas Medicine (EDIT): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 19.5% short float

Options Flow▲ 0.35 P/C ratio

Insider Activity▼ Net Seller (30d)

Analyst Consensus

Buy

19 analysts

Options Flow (P/C)

0.35

More calls — Bullish

52 calls · 18 puts

Avg Consensus PT

+155.8%

Highest Price Target

$15

+476.9%

Citigroup

Lowest Price Target

+15.4%

HC Wainwright & Co.

Short Interest

19.5%

Declining — Bullish

Insider Activity (30d)

Net Seller

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Sep 23, 2026	Guggenheim	Debjit Chattopadhyay—	+92.3%	$5	Upgrade	Neutral→Buy
Aug 18, 2026	Ladenburg Thalmann	——	+130.8%	$6	Initiate	Buy
May 5, 2026	Chardan Capital	Geulah Livshits—	+53.8%	$4 → $4	Maintained	Buy
Mar 10, 2026	Jones Trading	Soumit Roy—	+207.7%	$8	Upgrade	Hold→Buy
Mar 9, 2026	Chardan Capital	Geulah Livshits—	+34.6%	$4 → $4	Maintained	Buy
Sep 5, 2025	HC Wainwright & Co.	Mitchell S. Kapoor—	+92.3%	$5 → $5	Maintained	Buy
Sep 3, 2025	Wells Fargo	Yanan Zhu—	+53.8%	$3 → $4	Maintained	Equal-Weight
Aug 15, 2025	HC Wainwright & Co.	Mitchell S. Kapoor—	+92.3%	$3 → $5	Maintained	Buy
Aug 13, 2025	Baird	Joel Beatty—	+130.8%	$4 → $6	Maintained	Outperform
May 13, 2025	Baird	Joel Beatty—	+53.8%	$8 → $4	Maintained	Outperform
Apr 28, 2025	HC Wainwright & Co.	Mitchell Kapoor—	+15.4%	$3	Initiate	Buy
Dec 16, 2024	Evercore ISI Group	Liisa Bayko—	+92.3%	$7 → $5	Maintained	Outperform
Dec 16, 2024	JP Morgan	Brian Cheng—	—	—	Downgrade	Neutral→Underweight
Dec 13, 2024	RBC Capital	Luca Issi—	+53.8%	$5 → $4	Maintained	Sector Perform
Dec 13, 2024	Barclays	Gena Wang—	+15.4%	$5 → $3	Maintained	Equal-Weight
Dec 13, 2024	Chardan Capital	Geulah Livshits—	—	—	Downgrade	Buy→Neutral
Dec 13, 2024	Baird	Joel Beatty—	+207.7%	$10 → $8	Maintained	Outperform
Dec 13, 2024	Stifel	Dae Gon Ha—	+15.4%	$11 → $3	Downgrade	Buy→Hold
Dec 11, 2024	Wells Fargo	Yanan Zhu—	+53.8%	$7 → $4	Downgrade	Overweight→Equal-Weight
Nov 5, 2024	Chardan Capital	Geulah Livshits—	+361.5%	$12 → $12	Maintained	Buy
Nov 5, 2024	RBC Capital	Luca Issi—	+92.3%	$8 → $5	Maintained	Sector Perform
Nov 5, 2024	Stifel	Dae Gon Ha—	+323.1%	$17 → $11	Maintained	Buy
Nov 5, 2024	Truist Securities	Joon Lee—	+207.7%	$12 → $8	Maintained	Buy
Nov 5, 2024	Wells Fargo	Yanan Zhu—	+169.2%	$9 → $7	Maintained	Overweight
Nov 5, 2024	Barclays	Gena Wang—	+92.3%	$7 → $5	Maintained	Equal-Weight